Literature DB >> 23001884

Misfolded proteins recognition strategies of E3 ubiquitin ligases and neurodegenerative diseases.

Deepak Chhangani1, Nihar Ranjan Jana, Amit Mishra.   

Abstract

Impairment in the clearance of misfolded proteins by functional proteins leads to various late-onset neurodegenerative diseases. Cell applies a strict quality control mechanism against malfunctioned proteins which may generate cellular proteoxicity. Under proteotoxic insults, cells immediately adopt two major approaches to either refold the misfolded proteinaceous species or degrade the unmanageable candidates. However, the main cellular proteostasis quality control mechanism is not clear. It is therefore important to understand the events and cellular pathways, which are implicated in the clearance of recalcitrant proteins. Ubiquitin proteasome system manages intracellular protein degradation. In this process, E3 ubiquitin ligase enzyme provides specificity for recognition of client proteins. In this review, we summarize various molecular approaches governed by E3 ubiquitin ligases in the degradation of aberrant proteins. A clear understanding of E3 ubiquitin ligases can offer a well tractable therapeutic approach against neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001884     DOI: 10.1007/s12035-012-8351-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  113 in total

1.  A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

Authors:  M Koegl; T Hoppe; S Schlenker; H D Ulrich; T U Mayer; S Jentsch
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

Review 2.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 3.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Authors:  Matthew S Gentry; Carolyn A Worby; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-01       Impact factor: 11.205

5.  Proteins as molecular chaperones.

Authors:  J Ellis
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

6.  Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin.

Authors:  Sudheendra N R Rao; Ranjan Maity; Jaiprakash Sharma; Parthanarayan Dey; Susarla Krishna Shankar; Parthasarathy Satishchandra; Nihar Ranjan Jana
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

Review 7.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

Review 8.  How does parkin ligate ubiquitin to Parkinson's disease?

Authors:  Philipp J Kahle; Christian Haass
Journal:  EMBO Rep       Date:  2004-07       Impact factor: 8.807

9.  Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.

Authors:  Shweta Singh; Parthasarathy Satishchandra; Susarla Krishna Shankar; Subramaniam Ganesh
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

10.  Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.

Authors:  Dairin Kieran; Bernadett Kalmar; James R T Dick; Joanna Riddoch-Contreras; Geoffrey Burnstock; Linda Greensmith
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

View more
  9 in total

Review 1.  Autophagy coupling interplay: can improve cellular repair and aging?

Authors:  Deepak Chhangani; Sachin Chinchwadkar; Amit Mishra
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

Review 2.  Mahogunin Ring Finger-1 (MGRN1), a Multifaceted Ubiquitin Ligase: Recent Unraveling of Neurobiological Mechanisms.

Authors:  Arun Upadhyay; Ayeman Amanullah; Deepak Chhangani; Ribhav Mishra; Amit Prasad; Amit Mishra
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

Review 3.  Protein quality control system in neurodegeneration: a healing company hard to beat but failure is fatal.

Authors:  Deepak Chhangani; Amit Mishra
Journal:  Mol Neurobiol       Date:  2013-02-03       Impact factor: 5.590

4.  Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins.

Authors:  Deepak Chhangani; Arun Upadhyay; Ayeman Amanullah; Vibhuti Joshi; Amit Mishra
Journal:  Sci Rep       Date:  2014-05-28       Impact factor: 4.379

5.  Stress-induced NEDDylation promotes cytosolic protein aggregation through HDAC6 in a p62-dependent manner.

Authors:  Soyeon Kim; Mira Kwon; Yiseul Hwang; Junghyun Yoon; Sangwook Park; Ho Chul Kang
Journal:  iScience       Date:  2021-02-06

6.  Mahogunin ring finger-1 (MGRN1) suppresses chaperone-associated misfolded protein aggregation and toxicity.

Authors:  Deepak Chhangani; Amit Mishra
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 7.  Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome.

Authors:  Ayala Shiber; Tommer Ravid
Journal:  Biomolecules       Date:  2014-07-17

Review 8.  A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?

Authors:  Vibhuti Joshi; Ayeman Amanullah; Arun Upadhyay; Ribhav Mishra; Amit Kumar; Amit Mishra
Journal:  Front Mol Neurosci       Date:  2016-10-04       Impact factor: 5.639

9.  Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington's Disease.

Authors:  Arlin Keo; N Ahmad Aziz; Oleh Dzyubachyk; Jeroen van der Grond; Willeke M C van Roon-Mom; Boudewijn P F Lelieveldt; Marcel J T Reinders; Ahmed Mahfouz
Journal:  Front Mol Neurosci       Date:  2017-11-30       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.